PT79411B - Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochloride - Google Patents

Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochloride

Info

Publication number
PT79411B
PT79411B PT79411A PT7941184A PT79411B PT 79411 B PT79411 B PT 79411B PT 79411 A PT79411 A PT 79411A PT 7941184 A PT7941184 A PT 7941184A PT 79411 B PT79411 B PT 79411B
Authority
PT
Portugal
Prior art keywords
prazosina
hydrochloride
preparing
stable crystalline
novel anhydrous
Prior art date
Application number
PT79411A
Other languages
English (en)
Other versions
PT79411A (en
Inventor
Stig Olof Engelbert Lindholm
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of PT79411A publication Critical patent/PT79411A/pt
Publication of PT79411B publication Critical patent/PT79411B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT79411A 1984-06-25 1984-10-26 Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochloride PT79411B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI842544A FI79107C (fi) 1984-06-25 1984-06-25 Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Publications (2)

Publication Number Publication Date
PT79411A PT79411A (en) 1984-11-01
PT79411B true PT79411B (en) 1986-09-15

Family

ID=8519293

Family Applications (1)

Application Number Title Priority Date Filing Date
PT79411A PT79411B (en) 1984-06-25 1984-10-26 Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochloride

Country Status (17)

Country Link
US (2) US4739055A (pt)
JP (1) JPS6115881A (pt)
AT (1) AT389117B (pt)
AU (1) AU566814B2 (pt)
BE (1) BE900925A (pt)
CH (1) CH661045A5 (pt)
DE (1) DE3429415A1 (pt)
FI (1) FI79107C (pt)
FR (1) FR2567124B1 (pt)
GB (1) GB2160861B (pt)
IL (1) IL73267A (pt)
IT (1) IT1224142B (pt)
LU (1) LU85616A1 (pt)
NL (1) NL8403250A (pt)
NZ (1) NZ209962A (pt)
PT (1) PT79411B (pt)
ZA (1) ZA85910B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0237608B1 (de) * 1986-03-21 1992-01-29 HEUMANN PHARMA GMBH & CO Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
JP2756846B2 (ja) * 1989-12-28 1998-05-25 住化ファインケム株式会社 無水のε型結晶体2―〔4―(2―フロイル)ピペラジン―1―イル〕―4―アミノ―6,7―ジメトキシキナゾリン塩酸塩及びその製造方法
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
ES2282386T3 (es) * 2001-02-24 2007-10-16 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Derivados de xantina, su preparacion y su uso como medicamentos.
US7407955B2 (en) * 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) * 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CA2810522A1 (en) 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh Polymorphs
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
KR101610005B1 (ko) * 2007-08-17 2016-04-08 베링거 인겔하임 인터내셔날 게엠베하 Fab 관련 질환의 치료에 사용하기 위한 푸린 유도체
AR071175A1 (es) * 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
BRPI0917675A2 (pt) * 2008-08-15 2015-12-01 Boehringer Ingelheim Int compostos orgânicos para cura de ferida
EP2344195A2 (en) 2008-09-10 2011-07-20 Boehringer Ingelheim International GmbH Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP2012512848A (ja) 2008-12-23 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 有機化合物の塩の形態
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
BR112012012641A2 (pt) 2009-11-27 2020-08-11 Boehringer Ingelheim International Gmbh TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA
CA2797310C (en) 2010-05-05 2020-03-31 Boehringer Ingelheim International Gmbh Glp-1 receptor agonist and dpp-4 inhibitor combination therapy
AU2011268940B2 (en) 2010-06-24 2015-05-21 Boehringer Ingelheim International Gmbh Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US8962636B2 (en) 2011-07-15 2015-02-24 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP2849755A1 (en) 2012-05-14 2015-03-25 Boehringer Ingelheim International GmbH A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2015128453A1 (en) 2014-02-28 2015-09-03 Boehringer Ingelheim International Gmbh Medical use of a dpp-4 inhibitor
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2969375A (en) * 1961-01-24 Certification of correction
DE156532C (pt) *
NL54420C (pt) * 1937-05-25
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3433788A (en) * 1966-04-27 1969-03-18 Union Carbide Corp Process for recovery of amines from aqueous solutions by solvent treatment and distillation
US3421983A (en) * 1967-03-07 1969-01-14 Lummus Co Azeotropic distillation of aqueous toluene diamine
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3743672A (en) * 1970-05-27 1973-07-03 Halcon International Inc Separation of water in alkylene glycol mono and diester purification by azeotropic distillation
GB1308718A (en) * 1970-07-01 1973-03-07 Sir Soc Italiana Resine Spa Method of separating vinyl acetate from liquid mixtures
IT956765B (it) * 1972-06-22 1973-10-10 Montedison Spa Procedimento per la purificazione di 1 3 diossolano
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI64367C (fi) * 1980-02-26 1986-08-05 Orion Yhtymae Oy Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid

Also Published As

Publication number Publication date
FI842544A (fi) 1985-12-26
NL8403250A (nl) 1986-01-16
IL73267A (en) 1988-06-30
FI842544A0 (fi) 1984-06-25
BE900925A (fr) 1985-02-15
GB8424999D0 (en) 1984-11-07
GB2160861B (en) 1987-11-18
LU85616A1 (fr) 1985-06-04
NZ209962A (en) 1987-06-30
AU566814B2 (en) 1987-10-29
FR2567124B1 (fr) 1990-09-21
ZA85910B (en) 1985-09-25
FR2567124A1 (fr) 1986-01-10
FI79107C (fi) 1989-11-10
DE3429415C2 (pt) 1990-05-03
CH661045A5 (de) 1987-06-30
PT79411A (en) 1984-11-01
DE3429415A1 (de) 1986-01-02
US4873330A (en) 1989-10-10
IT1224142B (it) 1990-09-26
GB2160861A (en) 1986-01-02
AT389117B (de) 1989-10-25
JPS6115881A (ja) 1986-01-23
JPH0481993B2 (pt) 1992-12-25
US4739055A (en) 1988-04-19
AU3451084A (en) 1986-01-02
IT8423292A0 (it) 1984-10-24
IL73267A0 (en) 1985-01-31
ATA344184A (de) 1989-03-15
FI79107B (fi) 1989-07-31

Similar Documents

Publication Publication Date Title
PT79411B (en) Process for preparing a novel anhydrous stable crystalline delta-form of prazosina hydrochloride
EG18398A (en) Process for preparing of piperazinyl-heterocyclic compounds
HUT44257A (en) Process for preparing crystalline cefalosporinhydrate
EG19303A (en) Process for preparing of new therapeutically active compound
DE3573066D1 (en) Process for preparing a solution of inverted micellae
CS489688A2 (en) Method of crystalline citromycindihydrate production
BG49825A3 (en) Method for preparing of 10- dihydro- 10- deoxo- 11- asaeritronolides a
PT80916A (en) Process for preparing novel crystal modification
PT81566B (en) Process for preparing amino-salicylic acid derivatives
ZA859130B (en) Synthesis of a crystalline silicoalumino phosphate
PT83480A (en) Process for preparing amine salts of lignosulfonates
PT82308A (en) Process for preparing pesticidal compositions containing a novel anilinobenzodioxole compound
HUT40115A (en) Process for preparing sylbinine free of isosylbine
YU184588A (en) Process for obtaining crystalline monohydrate form of 1-carbacephalosporine
PT79792A (en) Process for preparing crystalline silicic acid and salts thereof
DE3563208D1 (en) A process for producing n-substituted maleimides
HUT43992A (en) Process for production of crystalline metall-gluconates
PL256016A1 (en) Process for preparing novel derivatives of 6-hydroxymethylpenicillanic acid
GB2164326B (en) Process for synthesis of crystalline aluminosilicate
HUT38357A (en) Process for producing a cepheme-carboxylic acid derivative /cephtazidim/
EG17668A (en) Process for preparing of a bromodichlorimidazole insecticide
YU45030B (en) Process for preparing crystalline cimetidine
HUT36800A (en) Process for preparing carbamidic acid derivatives
CS987985A1 (en) Crystalline form of a 1-benzydril-4-aryl--piperazindyhydrochloride and process for preparing thereof
GR871051B (en) A process for preparing an acylated heterocyclic compound

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960331